Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formataffinity purified
Size0.01 mg, 0.02 mg, 0.05 mg
Concentration200ug/ml
ApplicationsWestern Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody is a rabbit polyclonal antibody raised against CELSR3. It has beenselected for its ability to recognize CELSR3 in immunohistochemical staining andwestern blotting.
ImmunogenImmunogen: Recombinant CELSR3 (Ser1181~Cys1421) expressed in E Coli. Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2078054
Other Names[cadherin EGF LAG seven-pass G-type receptor 3; Cadherin EGF LAG seven-pass G-type receptor 3; cadherin EGF LAG seven-pass G-type receptor 3; cadherin EGF LAG seven-pass G-type receptor 3; Cadherin family member 11; Epidermal growth factor-like protein 1; EGF-like protein 1; Flamingo homolog 1; hFmi1; Multiple epidermal growth factor-like domains protein 2; Multiple EGF-like domains protein 2]
Gene, Accession #[CELSR3], Gene ID: 1951, NCBI: NP_001398.2, UniProt: Q9NYQ7
Catalog #MBS2025896
Price$110, $130, $175
Order / More InfoCadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.